August 22, 2008 - The 23rd Annual Advances in Contrast Ultrasound: Atherosclerosis Imaging and Interventions/Bubble Course will explore applications of contrast ultrasound Sept. 18-19 at the Millennium Knickerbocker Hotel in Chicago.
August 22, 2008 - St. Jude Medical Inc. this week said the FDA approved of the company’s new facility in Arecibo, Puerto Rico, for the manufacturing of pacemakers and cardiac leads.
August 22, 2008 – The 21st annual Healthcare Facilities Symposium and Expo Sept. 9-11, 2008 at Navy Pier in Chicago ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
August 21, 2008 - CardioECG 3.2, introduced by LUMEDX Corp. and Epiphany Cardiography Products, is a multimodality ...
August 21, 2008 – The first U.S. patient implanted with the DuraHeart Left Ventricular Assist System (LVAS) was ...
August 20, 2008 - Royal Philips Electronics said today it will lead a new European Union-funded research project called ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
August 20, 2008 - Diagnostic testing conducted at or near the site of the patient, known as patient-side point-of-care ...
August 20, 2008 — FiatLux Imaging Inc. — a high-tech company founded by former Microsoft software veterans — said the ...
Bracco's Isovue (iopamidol injection) X-ray/CT contrast is reportedly a safe and effective nonionic contrast agent, which is well established with U.S. clinical experience since 1986. Worldwide, more than 250 million doses of iopamidol have been administered, the company said.
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
August 19, 2008 - Dräger Medical Inc. today said its Fabius MRI anesthesia machine received FDA clearance, and is designed specifically to meet the requirements for the magnetic resonance imaging (MRI) environment.
August 19, 2008 - FiatLux Imaging Inc. today released its FiatLux Visualize medical imaging application that capitalizes ...
St. Jude Medical Inc. received European CE Mark approval and FDA clearance for the Epicor LP Cardiac Ablation System, a second generation technology that uses HIFU (high intensity focused ultrasound) to surgically ablate cardiac tissue to disrupt abnormal electrical impulses in the heart.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
August 18, 2008 - Atritech Inc. today said it filed its pre-market approval application (PMA) with the FDA for its WATCHMAN Left Atrial Appendage (LAA) Closure Technology, which contains the results of the PROTECT AF Clinical Trial which began enrollment in early 2005.
August 19, 2008 – St. Jude Medical Inc. said today it received European CE Mark approval and FDA clearance for the ...
FiatLux Imaging Inc. offers its FiatLux Visualize medical imaging application that capitalizes on advanced video game ...
August 21, 2008
